We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Alliance for New Automation Technologies

By Labmedica staff writers
Posted on 30 Jan 2005
In a move that will give the company immediate access to new automation technologies and ensure a steady stream of leading-edge capabilities, Dade Behring (Deerfield, IL, USA) has entered into a partnership with Inpeco (Milan, Italy).

Inpeco has been working with many major companies and institutions in the in vitro diagnostics (IVD), pharmaceutical, and life sciences sectors. More...
Product quality and innovation are the company's major goals. "Our business strategy focuses on key technologies in the IVD industry that benefit from expertise in automation,” commented Andrea Pedrazzini, president of Inpeco. "Having already worked closely with Dade Behring to develop one of their current automation solutions, StreamLAB, we are certain this automation partnership will be unparalleled by any other in the marketplace.”

"Interest in our StreamLAB solution continues to increase globally,” noted Rick Lee, corporate vice president, global marketing, at Dade Behring. "This partnership supports our unique approach to automation, which is focused on creating individualized solutions based on customer needs and requirements.”



Related Links:
Dade Behring
Inpeco

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.